Pharmaceutical

Tahoe Therapeutics Secures $30M for AI Cancer Research
Clinical & Pharma Tahoe Therapeutics Secures $30M for AI Cancer Research

In a groundbreaking stride for medical innovation, Tahoe Therapeutics Inc., a San Francisco-based startup, has recently clinched an impressive $30 million in funding to propel its mission of revolutionizing cancer research through artificial intelligence (AI). This substantial investment serves as

Jazz Pharmaceuticals Stock Surges on FDA Drug Approval
Clinical & Pharma Jazz Pharmaceuticals Stock Surges on FDA Drug Approval

In a remarkable turn of events for the biopharmaceutical industry, Jazz Pharmaceuticals (NASDAQ:JAZZ) has captured significant market attention with a sharp rise in its stock price, fueled by a pivotal regulatory achievement that marks a turning point for the company. This surge, recorded at 4.8%

Coroner Warns of Fatal Flaws in Penicillin Allergy Checks
Clinical & Pharma Coroner Warns of Fatal Flaws in Penicillin Allergy Checks

In a deeply troubling incident that has reverberated through the medical field, Margaret McNaughton tragically passed away on December 13, 2024, at New Cross Hospital in Wolverhampton, UK, after suffering a fatal allergic reaction to a penicillin-based antibiotic. Despite her documented allergy to

How Will Trump's Tariffs Impact Ireland's Pharma Industry?
Clinical & Pharma How Will Trump's Tariffs Impact Ireland's Pharma Industry?

President Donald Trump's recent announcement of potential tariffs on imported pharmaceuticals has sent shockwaves through global markets, with Ireland, a powerhouse in the pharmaceutical sector, standing at the forefront of concern. As a key supplier to the U.S. market, Ireland faces the daunting

Takeda Pharmaceutical Stock: Mixed Signals and Outlook
Clinical & Pharma Takeda Pharmaceutical Stock: Mixed Signals and Outlook

In the ever-shifting landscape of the pharmaceutical industry, Takeda Pharmaceutical Co ADR (TAK) stands as a notable contender, drawing significant attention from investors navigating the complexities of the stock market. With a market capitalization of $44.28 billion and a workforce of over

Can Trump Force Big Pharma to Slash US Drug Prices?
Clinical & Pharma Can Trump Force Big Pharma to Slash US Drug Prices?

Imagine a scenario where the cost of life-saving medications in the United States drops dramatically overnight, easing the financial burden on millions of families who struggle to afford essential drugs. This vision is at the heart of a recent bold move by President Donald Trump, who has directly

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later